BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19538171)

  • 1. Glutathione transferases as targets for cancer therapy.
    Ruzza P; Rosato A; Rossi CR; Floreani M; Quintieri L
    Anticancer Agents Med Chem; 2009 Sep; 9(7):763-77. PubMed ID: 19538171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glutathione Transferase (GST)-Activated Prodrugs.
    Ruzza P; Calderan A
    Pharmaceutics; 2013 Apr; 5(2):220-31. PubMed ID: 24300447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutathione transferases and development of new principles to overcome drug resistance.
    Sau A; Pellizzari Tregno F; Valentino F; Federici G; Caccuri AM
    Arch Biochem Biophys; 2010 Aug; 500(2):116-22. PubMed ID: 20494652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of glutathione-S-transferase in anti-cancer drug resistance.
    Townsend DM; Tew KD
    Oncogene; 2003 Oct; 22(47):7369-75. PubMed ID: 14576844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advance in antitumor agents targeting glutathione-S-transferase.
    Zhao G; Wang X
    Curr Med Chem; 2006; 13(12):1461-71. PubMed ID: 16719788
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective inhibitors of glutathione transferase P1 with trioxane structure as anticancer agents.
    Bräutigam M; Teusch N; Schenk T; Sheikh M; Aricioglu RZ; Borowski SH; Neudörfl JM; Baumann U; Griesbeck AG; Pietsch M
    ChemMedChem; 2015 Apr; 10(4):629-39. PubMed ID: 25694385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione Transferases: Potential Targets to Overcome Chemoresistance in Solid Tumors.
    Pljesa-Ercegovac M; Savic-Radojevic A; Matic M; Coric V; Djukic T; Radic T; Simic T
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30487385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and molecular modeling of new benzimidazoles as glutathione S-transferase inhibitors and anticancer agents.
    Abd El-Karim SS; Anwar MM; Zaki ER; Elseginy SA; Nofal ZM
    Future Med Chem; 2018 Jan; 10(2):157-181. PubMed ID: 29235906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of GSTπ isoform in the cells signalling and anticancer therapy.
    Ściskalska M; Milnerowicz H
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8537-8550. PubMed ID: 32894559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chemistry and biology of inhibitors and pro-drugs targeted to glutathione S-transferases.
    Mahajan S; Atkins WM
    Cell Mol Life Sci; 2005 Jun; 62(11):1221-33. PubMed ID: 15798895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human cytosolic glutathione transferases: structure, function, and drug discovery.
    Wu B; Dong D
    Trends Pharmacol Sci; 2012 Dec; 33(12):656-68. PubMed ID: 23121834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytoprotective and regulatory functions of glutathione S-transferases in cancer cell proliferation and cell death.
    Singh S
    Cancer Chemother Pharmacol; 2015 Jan; 75(1):1-15. PubMed ID: 25143300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overcoming resistance to cisplatin by inhibition of glutathione S-transferases (GSTs) with ethacraplatin micelles in vitro and in vivo.
    Li S; Li C; Jin S; Liu J; Xue X; Eltahan AS; Sun J; Tan J; Dong J; Liang XJ
    Biomaterials; 2017 Nov; 144():119-129. PubMed ID: 28834763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structures of class pi glutathione S-transferase from human placenta in complex with substrate, transition-state analogue and inhibitor.
    Prade L; Huber R; Manoharan TH; Fahl WE; Reuter W
    Structure; 1997 Oct; 5(10):1287-95. PubMed ID: 9351803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 7-Nitro-2,1,3-benzoxadiazole derivatives, a new class of suicide inhibitors for glutathione S-transferases. Mechanism of action of potential anticancer drugs.
    Ricci G; De Maria F; Antonini G; Turella P; Bullo A; Stella L; Filomeni G; Federici G; Caccuri AM
    J Biol Chem; 2005 Jul; 280(28):26397-405. PubMed ID: 15888444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An inhibitor of glutathione S-transferase omega 1 that selectively targets apoptotic cells.
    Pace NJ; Pimental DR; Weerapana E
    Angew Chem Int Ed Engl; 2012 Aug; 51(33):8365-8. PubMed ID: 22777685
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemical Reactivity Window Determines Prodrug Efficiency toward Glutathione Transferase Overexpressing Cancer Cells.
    van Gisbergen MW; Cebula M; Zhang J; Ottosson-Wadlund A; Dubois L; Lambin P; Tew KD; Townsend DM; Haenen GR; Drittij-Reijnders MJ; Saneyoshi H; Araki M; Shishido Y; Ito Y; Arnér ES; Abe H; Morgenstern R; Johansson K
    Mol Pharm; 2016 Jun; 13(6):2010-25. PubMed ID: 27093577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutathione S-transferases: an overview in cancer research.
    Di Pietro G; Magno LA; Rios-Santos F
    Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):153-70. PubMed ID: 20078251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Multifaceted Role of Glutathione S-Transferases in Health and Disease.
    Mazari AMA; Zhang L; Ye ZW; Zhang J; Tew KD; Townsend DM
    Biomolecules; 2023 Apr; 13(4):. PubMed ID: 37189435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.
    Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM
    Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.